Pièces relatives à l'histoire de la ville de TULLE. V

Contient : Pièces relatives au procès soutenu par Jean Melon, syndic du clergé du diocèse de Tulle, demandeur en crime de faux, contre Joseph de Lespinasse, conseiller au siège présidial de ladite ville, relativement au testament de François de La Garde, élu de Tulle ; Testament, dudit F. de La Garde (7 février 1681) ; imprimé (Corda, Catal. des Factums, t. II, p. 337) ; Copie manuscrite du même testament et de pièces relatives à l'instance introduite par Jean Melon (avril 1684) ; Mémoire manuscrit adressé au Parlement par le même (s. d.) ; Pièces imprimées relatives à la même affaire ; Factum du procez par ledit J. Melon contre J.-J. de Lespinasse ; Observations sommaires sur le factum de M. de Lespinasse ; Procez verbal et raport des experts commis en cette affaire par le Parlement de Guyenne ; Factum pour M. J.-J. de Lespinasse contre M. R. Gaye, directeur du séminaire de Tulle, J. Melon et les héritiers ab intestat de Fr. de La Garde (30 août 1688) (Corda, Catal. des factums, t. III, p. 324) ; Réflexions de J. Melon sur le factum de J.-J. de Lespinasse (ibid.) ; Mémoire pour J. Melon et R. Gaye contre les héritiers de Fr. de La Garde ; Factum... servant de contredits pour M. R. Gaye contre Fr. de Saint-Priest (Corda, Cat. des Factums, t. II, p. 336) ; Mémoire particulier touchant la dépense de l'état du même (ibid.) ; Mémoire pour les maire et consuls de Tulle contre les héritiers de M. de La Garde et M. Melon (Corda, op. cit., t. VI, p. 193) ; Salvations pour Fr. de Saint-Priest et consorts contre Me Raymond Gaye ; Pièces manuscrites relatives au séminaire de Tulle : ; Arrêts de Parlement concernant les droits dudit séminaire dans l'affaire précédente (23 janvier-4 septembre 1692) ; Pièces concernant l'union du séminaire de Tulle à celui de Saint-Sulpice à Paris (28 mars 1697-19 juillet 1698) ; Mémoire sur les différends entre l'évêque de Tulle et l'hôpital général de ladite ville ; Procès-verbal de la réunion tenue audit hôpital le 11 juin 1696 ; Recueil de pièces imprimées concernant l'hôpital général de Tulle : ; Établissement d'un hôpital général dans la ville de Tulle par lettres patentes du mois de décembre 1670 (Tulle, 1687) ; Mémoire pour les administrateurs de l'hôpital de Tulle, contre M. Ancelin, évêque de cette ville (Corda, op. cit., t. VI, p. 193) ; Mémoire sur le même sujet, signé Melon (ibid.) ; Autre Mémoire sur le même sujet, signé Delarue (ibid.) ; Factum pour les doyen et chapitre de la cathédrale de Tulle, contre Gaspard Daudebert, curé de Salgues

Designing phase III or IV trials for vaccines: choosing between individual or cluster randomised trial designs.

The choice of design between individual randomisation, cluster or pseudo-cluster randomisation is often made difficult. Clear methodological guidelines have been given for trials in general practice, but not for vaccine trials. This article proposes a decisional flow-chart to choose the most adapted design for evaluating the effectiveness of a vaccine in large-scale studies. Six criteria have been identified: importance of herd immunity or herd protection, ability to delimit epidemiological units, homogeneity of transmission probability across sub-populations, population's acceptability of randomisation, availability of logistical resources, and estimated sample size. This easy to use decisional method could help sponsors, trial steering committees and ethical committees adopt the most suitable design.

Psychopharmacology in supportive care of cancer: a review for the clinician. III. Antidepressants

This review covers pharmacokinetics, adverse effects and drug interactions of antidepressants and the indications for them, with the aim of assisting the clinician working in palliative and supportive care in the prescription of such drugs. Practical considerations and decision trees to be used prior to the prescription of an antidepressant are also part of this review. Special emphasis is put on the management of depression, which is frequent in patients with advanced cancer and often remains underdetected and undertreated, or is treated at a stage when there is little time for medication to have an effect.

Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trial.

PURPOSE: From February 2001 to February 2002, 946 patients with advanced GI stromal tumors (GISTs) treated with imatinib were included in a controlled EORTC/ISG/AGITG (European Organisation for Research and Treatment of Cancer/Italian Sarcoma Group/Australasian Gastro-Intestinal Trials Group) trial. This analysis investigates whether the response classification assessed by RECIST (Response Evaluation Criteria in Solid Tumors), predicts for time to progression (TTP) and overall survival (OS). PATIENTS AND METHODS: Per protocol, the first three disease assessments were done at 2, 4, and 6 months. For the purpose of the analysis (landmark method), disease response was subclassified in six categories: partial response (PR; > 30% size reduction), minor response (MR; 10% to 30% reduction), no change (NC) as either NC- (0% to 10% reduction) or NC+ (0% to 20% size increase), progressive disease (PD; > 20% increase/new lesions), and subjective PD (clinical progression). RESULTS: A total of 906 patients had measurable disease at entry. At all measurement time points, complete response (CR), PR, and MR resulted in similar TTP and OS; this was also true for NC- and NC+, and for PD and subjective PD. Patients were subsequently classified as responders (CR/PR/MR), NC (NC+/NC-), or PD. This three-class response categorization was found to be highly predictive of further progression or survival for the first two measurement points. After 6 months of imatinib, responders (CR/PR/MR) had the same survival prognosis as patients classified as NC. CONCLUSION: RECIST perfectly enables early discrimination between patients who benefited long term from imatinib and those who did not. After 6 months of imatinib, if the patient is not experiencing PD, the pattern of radiologic response by tumor size criteria has no prognostic value for further outcome. Imatinib needs to be continued as long as there is no progression according to RECIST.

Identifying and Implementing Effective Training for Hispanic Craft Workers, American Supervisors, and DOT Inspectors: Phase III of the Hispanic Workforce Research Project, May 2006

The number of Hispanic workers in the U.S. construction industry has been steadily increasing, and language and cultural barriers have sometimes arisen on the jobsite. Due in part to these barriers, the number of fatalities among Hispanics at construction sites in 2001 jumped 24%, while construction fatalities overall dropped 3%. This study, which constitutes Phase III of the Hispanic Workforce Research Project, addresses these language and cultural barriers by investigating the most effective way to deliver training material developed in Phases I and II to Hispanic workers, American supervisors, and department of transportation (DOT) inspectors. The research methodology consisted of assessing the needs and interests of potential and current course participants in terms of exploring innovative ways to deliver the training. The training courses were then adapted and delivered to fit the specific needs of each audience. During Phase III of this project, the research team delivered the courses described in the Phase I and II reports to eight highway construction companies and two DOT groups. The courses developed in Phases I and II consist of four construction-focused language training courses that can be part of an effective training program to facilitate integration among U.S. and Hispanic workers, increase productivity and motivation at the jobsite, and decrease the existing high mortality rate for Hispanic workers. Moreover, the research team developed a course for the construction season called Toolbox Integration Course for Hispanic workers and American supervisors (TICHA), which consists of nine 45-minute modules delivered to one construction company over 11 weeks in the summer of 2005.

Petrus Aureoli, in librum III Sentenciarum.

Fonds non déterminé.